BASEL, Switzerland, Nov. 4 -- Hematology Reports, a peer-reviewed journal that says it covers all aspects of prevention, diagnosis and management of disorders of the blood, as well as related molecular and cell biology, genetics, pathophysiology, epidemiology and controlled trials, published research articles on the following topics in its June 2024 edition (Vol. 16, Issue 2):

* Article - Phase II Trial of Romidepsin as Consolidation Therapy after Gemcitabine, Dexamethasone, and Cis . . .

Click here for more information about our products